Best Penny Stocks To Add to Your Watchlist – April 24th

AEye, Elong Power, Bitfarms, Scinai Immunotherapeutics, and Keel Infrastructure are the five Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of very small or thinly traded companies that sell at very low prices—commonly under $5 per share—and are often traded over-the-counter rather than on major exchanges. They typically have low liquidity, high volatility, limited public disclosure, and a higher risk of fraud or price manipulation, making them highly speculative investments. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

AEye (LIDR)

AEye, Inc., together with its subsidiaries, provides lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications in the United States, Europe, and Asia-Pacific. It offers 4Sight intelligent sensing lidar platform, including 4Sight at Design, Triggered 4Sight, Responsive 4Sight, and Predictive 4Sight; and 4Sight for automotive and industrial market.

Read Our Latest Research Report on LIDR

Elong Power (ELPW)

Read Our Latest Research Report on ELPW

Bitfarms (BITF)

Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. It owns and operates server farms that primarily validates transactions on the Bitcoin Blockchain and earning cryptocurrency from block rewards and transaction fees. The company also provides electrician services to commercial and residential customers in Quebec, Canada.

Read Our Latest Research Report on BITF

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications.

Read Our Latest Research Report on SCNI

Keel Infrastructure (KEEL)

Read Our Latest Research Report on KEEL

Read More